Navigation Links
Beckman Coulter Affirms 2009 Outlook
Date:12/17/2009

gibles. The following is the EPS walk-forward presented at today's Annual Business Review:



                                                           Preliminary
                                                               2010
               2009 Outlook      2009           2009       Consolidated
                 BEC Only    ODS Dilution   Consolidated     Outlook
               ------------  ------------   ------------   ------------
    EPS*     $3.85 - $3.95     ($0.08)     $3.77 - $3.87   $4.40 -$4.55
    Share
     count      65.4 M                        67.4 M          71.3 M

* Adjusted, excluding ODS intangible amortization of $0.10 and $0.24 in 2009 and 2010, respectively. Also, excludes any impact from health care reform.

Full 2010 outlook will be provided by the company on February 11, 2010.

Investor Event

As previously announced, the company hosted its Annual Business Review in New York City, New York, on Thursday, December 17, 2009. A replay of the presentation webcast of Beckman Coulter's Annual Business Review can be accessed by visiting their website at http://www.beckmancoulter.com. To access the replay presentation webcast, select "go to IR" under "Investor Relations" and find the event listed under "Recent Webcasts / Presentations." The webcast will be archived on the company's website for future on-demand replay.

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improvi
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Beckman Coulter to Present at the 2009 Piper Jaffray Healthcare Conference
2. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
3. Beckman Coulter Announces Third Quarter 2009 Results
4. Beckman Coulter to Present at Upcoming Healthcare Conferences
5. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
6. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
7. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
8. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
9. Accumetrics Closes 2009 with Positive Outlook
10. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
11. Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Northstar Global Business Services, Inc. (OTCPink:MDIN) today ... made their final decision and has determined to ... effective December 15, 2014, and has resumed accepting ... book entry transfer services. All deposit restrictions have been ... fully "DTC Eligible", and has resumed electronic trading ...
(Date:12/17/2014)... , The new Dompé website ... concerning the biopharmaceutical Group,s national and international clinical research activities ... recently launched institutional website that is receiving accolades from all ... new chapter in the fascinating story of Drug Discovery   ... hub on the world of clinical research, ranging from information ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today announced completion of enrollment in its first Phase ... 3-month observations confirmed the 1-month findings that were ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today reported ... September 30, 2009. , For the third quarter of 2009, ... per share, compared to a net loss of $37.7 million, ... Weighted average shares outstanding for the third quarters of 2009 ...
... 2 The owner and operator of a Houston-area ... defrauding the Medicare program, announced Assistant Attorney General of ... Johnson of the Southern District of Texas and Daniel ... & Human Services (HHS). , Noel Wayne Jhagroo, 47, ...
Cached Medicine Technology:Rigel Announces Third Quarter 2009 Financial Results 2Rigel Announces Third Quarter 2009 Financial Results 3Rigel Announces Third Quarter 2009 Financial Results 4Rigel Announces Third Quarter 2009 Financial Results 5Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits" 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits" 3
(Date:12/22/2014)... Christmas is days away, and last minute gifts ... solution that will please: the Sublime Gift Card . ... $25 up to $350," says Kathy Heshelow, founder of ... wide array of skin care products and Skin Brushes." , ... , Gift delivery past shipping deadlines, or those last ...
(Date:12/22/2014)... (PRWEB) December 21, 2014 A ... for chest computed tomography (CT) to evaluate abnormal ... findings, including cancer, according to a new study ... Researchers said the findings show that radiologist recommendations ... valuable contributions to patient care. , RAIs, which ...
(Date:12/22/2014)... 2014 Parker & Sons, Inc. a ... Arizona home contracting services reports a record number of ... services in 2014. As a company that has served ... Parker and Sons is a business that is focused ... side-by-side with other top quality companies in Arizona that ...
(Date:12/21/2014)... December 22, 2014 Weddingshe.com, an outstanding ... gowns, has recently released its new selection of Cocktail ... are made according to the newest fashion trends. ... stunning dresses for cocktail parties . All of them ... percent off. We are making every effort to offer ...
(Date:12/21/2014)... 2014 When families in Coral Gables get ... call? The new answer is Lice Troopers . Located ... their newest treatment center will be the new go-to resource ... without the use of harmful chemicals or pesticides. ... 1, 2015. Like the company’s first clinic (located at 1005 ...
Breaking Medicine News(10 mins):Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
... March 23 InterMune, Inc. (Nasdaq: ITMN ... submitted on March 2 seeking approval of pirfenidone ... was validated by the European Medicines Agency (EMA). Validation of ... complete and that the review process will begin on ...
... ... Haiti survivors. , ... (PRWEB) March 23, 2010 -- Just like any other business, non-profit organizations must acquire ... VoiceNation,s call center agents and auto attendants assist to fill the need ...
... ... crisis in Haiti. The flexibility of these products can easily make a difference from tent ... ... line of solar lights brings vital illumination to residents and aid workers without electricity in ...
... ... us than first thought. , ... (Vocus) -- Long known for being an excellent source of fiber, two recent studies suggest that ... in antioxidants, previous research has suggested that apples may prevent or reduce the risks of certain ...
... PLoS Medicine finds that four risk factors ... explain a substantial amount of the disparity in life expectancy ... population that can be defined by race, and location and ... risk factors are estimated to reduce life expectancy in the ...
... Economic Studies: , ... , ... ... "The health care reform legislation passed by the United States House of Representatives ...
Cached Medicine News:Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 2Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 3Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 4Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 5Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 6Health News:The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone 7Health News:VoiceNation Helps Non-Profits Gather Funding for Those in Need 2Health News:VoiceNation Helps Non-Profits Gather Funding for Those in Need 3Health News:Bosoley Solar Light Set to Bring Haiti Out of the Post-Earthquake Darkness 2Health News:Go with Your Gut and Boost your Immune System with America's Favorite Fruit 2Health News:Go with Your Gut and Boost your Immune System with America's Favorite Fruit 3Health News:4 preventable risk factors reduce US life expectancy and lead to health disparities 2Health News:Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation 2Health News:Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: